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ABSTRACT 
Age-related macular degeneration (ARMD) ts the leading cause 
of blindness among the elderly in the United States. This study is an 
effort to develop a cost-effective testing protocol that can be used by 
eye care clinicians to identify who is likely to develop ARMD so that 
these individuals can receive preventive care. This study is part of a 
nationwide, multi-center, double-masked project on the effectiveness 
of antioxidant vitamin/mineral supplementation to treat ARMD. Five 
testing procedures used to diagnose ARMD were evaluated: foveal 
red threshold automated perimetry, contrast sensitivity, Amsler grid, 
nutritional intake data analysis, and blood chemistry analysis. The 
results indicate that normal subjects and those with ARMD have 
different results when tested using these procedures. When these 
tests are used in combination, they provide a strong protocol for 
identifying individuals who are likely to develop ARMD. 
KEY WORDS 
age-related macular degeneration, visual function, antioxidants, 
vitamin/mineral supplements 
INTRODUCTION 
As the population of persons age 50 years and older in the 
United States continues to increase, the incidence of ocular disease 
associated with aging is also increasing. In the aging of the U.S . 
population, age-related cataract and age-related macular 
degeneration (ARMD) are the leading causes of visual impairment 
and blindness 1 ,2, Approximately 25% of people aged 65 years and 
older have some manifestation of ARMD including large or confluent 
drusen, retinal pigmentary changes, geographic atrophy, or exudative 
disease3. And, because the elderly are the fastest growing segment 
of the population, the prevalence of both these disorders is expected 
to increase dramatically during the next two decades. In addition, the 
dry form of ARMD does not have any form of treatment or cure, nor 
can we predict who is likely to acquire ARMD. 
In order to identify who is likely to develop ARMD, it is 
necessary to identify the possible causes and risk factors associated 
with the disease. Several approaches that have been taken include: 
1. Etiological studies of ARMD 
2. Antioxidant protection including dietary intake and blood 
levels. 
3. Blood chemistry 
4. Functional visual testing 
ETIOLOGICAL STUDIES OF ARMD 
Age-related macular degeneration 1s a puzzling disease of 
unknown etiology and the prediliction of the disease for the macula 
has never been fully explained. In 1982, Klein and Klein4 examined 
the prevalence of ARMD with the use of data from the first National 
Health and Nutrition Examination Survey (NHANES-I) ophthalmology 
examination. Their study examined the prevalence of ARMD m 
relation to five variables: age , race , sex , hypertension, and 
hematocrit. The results of their analysis indicated a positive 
correlation of ARMD with both age and systolic hypertension. This 
positive association of hypertension and systolic blood pressure with 
ARMD in the Klein and Klein study is in accord with the results from 
the Framingham Eye Study5 and the case-control study of Delaney 
and Oates6. 
Recent research has suggested that light-generated free 
radicals play an important role in the etiology of ARMD 7-9. In living 
systems, free radicals are formed from both internal and external 
sources. Internally, free radicals are produced in cell structures 
including mitochondria and plasma membranes. Externally, free 
radicals result from light, ionizing radiation, air pollution, organic 
solvents and cigarette smoking 10, 11. The damage to tissues from 
these free radical attacks has been implicated in diseases such as 
cancer, atherosclerosis, heart disease, and strokes and is thought to 
contribute to aging10-13. 
In the eye, it is believed that free radicals are formed in the 
retina as a result of .light absorption by the photopigments and /or 
other materials in the outer segments of the photoreceptors, 
containing lipid molecules 14. These lipid molecules can be easily 
attacked by free radicals. When the 1 ipid molecules lose electrons, 
they are altered to become free radicals themselves. If the 
transformed lipids accumulate within the receptor outer segments, 
the probability of receptor injury/death increases. To reduce this 
from happening, sloughed portions of the outer segments are 
phagocytized by the retinal pigment epithelium (RPE). It is believed, 
however, that some of the transformed lipid molecules are not 
metabolized by the RPE's digestive enzymes due to their altered 
structure and, as a result, accumulate as lipofuscin inside the RPE 
cells 7. 
Evidence has been presented that lipofuscin accumulation in 
retinal pigmentary epithelium cells is responsible for ARMD. Dorey 
et at15 and others 16 • 1 7 have reported that the RPE in the area of 
the macula exhibits the greatest amount of lipofuscin and that the 
annular pattern in macular degeneration is well correlated with the 
area of greatest lipofuscin concentration 18. Most of the lipofuscin 
within the RPE may be derived from phagocytosis of oxidatively 
damaged (and other non-degradable) lipids in the photoreceptor 
outer segmentsl9. Therefore, RPE cells phagocytosing greater 
quantities of outer segment lipids may accumulate more lipofuscin. 
This material could be deposited onto Bruch's membrane in the form 
of drusen and could cause the RPE to separate from its blood supply 
in the choroid. This reduces the ability of the RPE to provide 
metabolic support to the photorecptors and could result in their 
death. Death of the receptors would be expected to lead to the 
reduction of central vision associated with ARMD. The data of Dorey 
et ai.l5 and others 19-21 support this hypothesis. 
ANTIOXIDANT PROTECTION 
Animal research and some epidemiological research have 
indicated a role for certain vitamins and trace minerals with 
antioxidant properties in protecting against the deterioration of 
macular degeneration. 
The role of micronutrients and exposure to light have been 
studied experimentally and have suggested a possible biological 
mechanism for the development of ARMD. Feeney and Berman22 
reported that exposure to ionizing radiation, ultraviolet light, or blue 
light, especially blue wavelengths, can lead to free radical formation. 
The free radicals are associated with the overall aging process23 and 
to lipid perioxidation of the photoreceptor outer segment membranes 
that are rich in polyunsaturated fatty acids24. Vitamins A, C, and E 
and the mineral selenium are known to function as antioxidants22, 
inhibiting cellular damage by acting as scavengers for the superoxide 
radicals. It is believed, therefore, that long-term deficiencies in 
antioxidants in the presence of free radical formation may be related 
to the development of ARMD. 
Young 8 suggested that micronutirents with antioxidant 
potential and a variety of trace minerals necessary for the proper 
functioning of some key enzyme systems may protect against ARMD. 
Antioxidants such as vitamins C and E, beta-carotene, glutathione, 
and selenium-dependent glutathione perioxidase could prevent 
cellular damage by acting as singlet oxyden and free radical 
scavengers. 
In 1988, Goldberg et at25 analyzed the data collected from the 
1971 and 1972 NHANES-I study to determine what factors were 
associated with ARMD. They reported that an increased frequency of 
consumption of fruits and vegetables rich in vitamins A and C 
reduced the risk of ARMD after a stratified adjustment for age. In a 
logistic regression analysis, adjusting for demographic and medical 
factors, the protective effect of vitamin C with age-related macular 
degeneration was no longer present. However, the frequency of 
consumption of fruits and vegetables rich in vitamin A remained 
correlated with a protective effect for ARMD even after the 
adjustment for demographic and medical factors. 
Newsome and Rothman26 demonstrated that zinc is taken up 
in vitro by human epithelial cells via a temperature saturable 
process. They suggested that zinc is strongly related to proper 
chorio-retinal functioning. Since ARMD involves a breakdown of the 
retinal pigment epithelium, it is suggested that the intake of zinc 
may prevent or slow down the process of ARMD. 
In 1982, Sandstead et ai.23 reported that zinc is a major 
deficiency in the elderly. Low zinc intake was related to poor taste 
acuity, poor healing, and immune dysfunction. They found that the 
daily dietary intake of zinc of groups of elderly persons in the U.S. 
range from 7 to 13 mg. As a result of their findings, they 
recommended that a threshold for zinc deficiency be defined and 
that zinc bioavailability be considered in food selection. 
In 1988, Newsome et ai.28 administered oral zinc sulfate 
supplements over a 2-year period to patients with ARMD. They 
found that these patients suffered significantly less vision loss than 
the controls. They compared macular photographs before and after 
treatment. The results of the photographs showed that the zinc-
treated patients either remained stable or had less accumulated 
drusen than did the controls. 
Richer29 hypothesized that reduced antioxidant defense of the 
retina secondary to poor nutrition and smoking combined with 
increased life expectancy and exposure to solar radiation provides a 
triple assault on the aging retina. Richer presented an overview of 
recent animal research and recent epidemiologic studies along with 
an overv1ew of ocular free-radical biochemistry to promote a 
conservative prevention/treatment strategy involving the 
identification of at-risk patients, solar radiation protection, 
nutritional counseling based upon the new USDA Food Pyramid 
concept and vitamin/mineral supplementation if necessary for non-
compliant, high-risk patients. 
The Eye Disease Case-Control Study30 evaluated the risk 
factors associated with neovascular age-related macular 
degeneration. Risk factors were assessed through interviews, clinical 
examination, and laboratory analysis of blood samples. Decreased 
risk of neovascular ARMD was associated with higher levels of 
carotenoids in the serum samples, higher horizontal cup to disk 
ratios, and the use of post-menopausal exogenous estrogens in 
women. Increased risk of neovascular ARMD was associated with 
cigarette smoking, higher levels of serum cholesterol, and parity 
greater than zero. No support was found for sunlight exposure, 
serum zinc levels, or iris color. Although no association was found 
with a history of cardiovascular disease itself, the associations with 
post-menopausal exogenous estrogen use, cigarette smoking, and 
serum cholesterol were seen by the authors as a hypothesis linking 
risk factors for cardiovascular disease with neovascular ARMD. The 
association noted between serum carotenoid levels and neovascular 
ARMD supported that hypothesis that higher levels of micronutrients 
with antioxidant properties may decrease the risk of ARMD. 
Liles et aJ.31 quantified the antioxidant enzymes catalase and 
superoxide dismutase activity in the RPE, retina, iris, and vitreous 
from human donors. They evaluated whether aging or macular 
degeneration affects RPE catalase or superoxide dismutase activities. 
Measurements of enzyme levels in the RPE from donors aged 50-90 
years with and without ARMD were obtained. Superoxidase 
dismutase activity showed no significant correlations with aging or 
ARMD. Catalase activity was found to decrease with age and ARMD 
in the macular and peripheral retinal pigment epithelium. 
A study by Prashar et al.3 2 was undertaken to assess the 
levels of antioxidant enzymes in red blood cells of subjects with 
ARMD and age-matched controls. The results indicated a significant 
decrease in the activities of superoxide dismutase. A correlation was 
also found between age and decreased activity of antioxidant 
enzymes m controls but the correlation with ARMD was higher. The 
researchers concluded that oxidative stress as assessed by 
antioxidant enzymes is more pronounced in patients with ARMD. 
These results contradict those found by Liles et al.31 presented 
above. 
The relationships between fasting plasma levels of retinol, 
ascorbic acid, alpha-tocopherol and beta-carotene and age-related 
macular degeneration were studied in a population of 976 
participants enrolled in the Baltimore Longitudinal Study of Aging 
(BLS A )3 3. The results indicated that alpha-tocopherol was 
associated with a protective effect for ARMD, adjusted for age, sex, 
and nuclear opacity. An antioxidant index, including ascorbic acid, 
alpha-tocopherol, and beta-carotene was also protective for ARMD. 
However, they reported that the use of vitamin supplementation to 
prevent ARMD was not supported by the data, which showed no 
protective effect of vitamin use. These findings are contrary to those 
reported by others8 ,34. 
West et al.33 also assessed fasting plasma, retinol, alpha-
tocopherol, ascorbic acid, and beta-carotene levels. The results 
suggested a protective effect for ARMD of high plasma levels of 
alpha-tocopherol. An antioxidant index composed of plasma ascorbic 
acid, alpha-tocopherol, and beta-carotene, was also protective. This 
study also showed no protective effect of vitamin supplementation. 
BLOOD CHEMISTRY 
There are virtually no studies evaluating the diagnostic or 
predictive value of blood chemistry tests with regard to ARMD. 
As discussed above, the Eye Disease Case-Control Study3 0 
evaluated the risk factors associated with ARMD. Risk factors were 
assessed through interviews, clinical examination, and laboratory 
analysis of blood samples. The results showed that neovascular 
ARMD was associated with higher levels of serum cholesterol. 
FUNCTIONAL VISUAL TESTING 
Since it is known that visual function decreases with age-
related macular degeneration, it should be possible to measure 
central visual function at an age in maturity prior to the onset of the 
disease and to predict who are the likely individuals to acquire 
ARMD. 
Several approaches to predicting ARMD have focused on 
identifying or developing functional tests that are more sensitive m 
identifying patients with early (pre-) ARMD or that are early 
predictors of who are likely individuals to develop ARMD. The 
functional tests which have received the greatest attention with 
regard to ARMD include automated perimetry, contrast sensitivity, 
and the Amsler grid. These tests were selected since they evaluate 
central visual function. 
AUTOMATED PERIMETRY 
ARMD is associated with central vision loss. In order to 
quantify this vision loss, many researchers have used various types 
of automated perimeters. 
In 1976, Greve et a].35, described the central and paracentral 
visual function in patients with drusen and in disciform macular 
degeneration and in the stages between these two extremes of the 
disease. Defects were measured using fluorescein angiography and 
function was measured using central single stimulus static perimetry 
at a mesopic and photopic level of adaptation. The study showed 
that differential static perimetry is a better indicator of the severity 
of the disease than fluorescein angiography. They study also 
demonstrated that differential static perimetry indicated severe 
paracentral defects when visual acuity was still good. 
Threshold static perimetry was performed by Hart and 
B urde3 6 using test object. patterns that covered contiguous areas of 
the central visual field. Computer imagery was used to display a 
three-dimensional surface that was interpolated between the 
sensitivity values at each of the test object locations. The 
examinations covered the area out to and including 10 degrees of 
eccentricity from the point of fixation, corresponding to the same 
area of the visual field covered by the Amsler grid. It was found 
that in a variety of macular diseases, including those caused by 
vascular, as well as primary degenerative disorders, central scotomas 
were characterized by relative sparing of visual sensitivity at the 
point of fixation. The pattern produced instead was one of a ring-
shaped depression within the central 10 degrees of the visual field. 
This phenomenon was present in 20% of cases with central scotomas 
resulting from macular disease, but was not found in any eye of 
patients suffering from central scotomas as a result of optic nerve 
disease. It was suggested by these authors that preservation of 
foveal sensitivity may be a marker for macular disease, as distinct 
from central visual field loss arising from optic nerve disease. 
Cone adaptation was measured in patients with ARMD and age-
related matched controls3 7. A red stimulus was used to selectively 
bias responses toward cone function and adaptation was measured 5, 
10, 20, and 40 degrees, with threshold difference reducing to 0.5 log 
units at 40 degrees. The data suggested that cone adaptation is 
significantly affected in ARMD patients, with raised cone thresholds 
occurring for areas well into the peripheral retina. The authors' data 
suggest that age-related "maculopathy" may not be confined to the 
macular area, and that early signs of the degeneration may be 
present in the peripheral retina even when central acuity is normal. 
In a related study3 8, reaction times to red lights of the same 
size and chromaticity as traffic signals were studied in normal 
elderly, pre-ARMD elderly, and ARMD elderly patients. The targets 
were projected under photopic and mesopic conditions with both 
central and fixation at 5 degrees eccentricity. The data showed 
greatly prolonged reaction time in the ARMD group compared to the 
normals. The pre-ARMD patients had results between the other two 
groups. The results indicate that functional changes are present 
before a definitive ARMD diagnosis can be made by conventional 
means. 
Peripheral retinal function in age-related macular degeneration 
was studied by Sunness et al. 3 9 . These researchers employed static 
perimetric measures of absolute thresholds at loci spanning the 
horizontal meridian of the retina to determine retinal function at 
specific locations. Absolute thresholds were measured on the 
Tubinger perimeter for 2 degrees, red (656nm), and blue-green 
(550nm) stimuli at 19 visual-field positions spanning the entire 
horizontal meridian. Absolute thresholds were measured using a 
method of ascending limits40. The results showed sensitivity loss m 
the central 20 degrees, but normal thresholds peripheral to this. The 
authors suggested that retinal function abnormalities in ARMD are 
confined to the central retina and the small age-related peripheral 
changes found do not correlate with the degree of ARMD. They also 
noted that there was no significant correlation of the magnitude of 
the loss with the degree of drusen present or with visual acuity. 
Automated perimetry was used in a study that evaluated 
foveal sensitivity as a predictor of macular degeneration41. This 
study was a prospective study of subjects who had participated in 
the earlier ARMD study of Sunness et al.3 9. The results of this study 
demonstrated that foveal dark-adapted sensitivity to a 1.8 degree 
red target was an excellent predictor of the subsequent development 
of advanced ARMD in eyes with drusen. 
Atchinson et al.4 2 studied the effects of early macular 
pigmentary and drusen changes on central visual fields in elderly 
patients with normal visual acuities. Visual field measurements 
were obtained using the Humphrey Field Analyzer's 24-2 and 10-2 
full-threshold programs. No significant differences were found 
between the two patient groups, one with and one without macular 
changes. The results found in this study conflict with those from 
previous studies in which functional losses were found in subjects 
with pre-ARMD38. 
Swann and Lovie-Kitchin43 investigated the nature of central 
visual field loss in ARMD and pre-ARMD patients and compared them 
with age-matched normal subjects. Central visual fields were 
examined using the Friedmann Visual Field Analyzer, Mark IT, the 
Bausch and Lomb Autoplot Tangent Screen and Amsler charts. The 
central visual field defects in ARMD were found to be predominantly 
paracentral with a relative sparing of foveal sensitiVIty. The pre-
ARMD subjects showed no significant visual field defects. 
Tolentino et at.44 evaluated visual field deficits in early age-
related macular degeneration. Their purpose was to determine 
whether deficits of form recognition as well as light sensitivity were 
related to RPE atrophy and/or drusen. Their findings indicated that 
the number of visual field defects by each test performed was 
significantly correlated with the areas of atrophy, but not with the 
area of drusen. There was also no significant tendency for a patient 
with a regional preponderance of drusen to have more impairment in 
the corresponding visual field. The authors suggested that deficits of 
form recognition and sensitivity in patients with early ARMD can be 
attributed to alteration of photoreceptor function associated with RPE 
atrophy, but not with drusen. 
It is well established that ARMD is associated with central 
visual field loss. Some studies attempting to quantify the visual field 
loss have been able to show a direct correspondence between the 
observable macular changes and the quantified field loss as 
measured by an automated perimeter. Other studies have not. 
CONTRAST SENSITIVITY 
Gratings and other spatially periodic visual stimuli of variable 
contrast have been demonstrated to be powerful tools in the study of 
the normal physiology of the visual system, but may also be equally 
powerful in the study of abnormal physiology45. Wolkstein et al.4 6 
studied contrast sensitivity findings in patients with retinitis 
pigmentosa, central serous retinopathy, glaucoma, and macular 
degeneration. Four patients with macular degeneration were tested. 
All four showed a high frequency deficit. However, there was a poor 
correlation between Snellen scores and the cut-off frequencies. In 
fact, three of the four subjects had cut-off frequencies better than 
predicted by the Snellen score. In normal subjects with 20/20 acuity 
or with reduced vision due to refractive error, the grating cut-off 
frequency was in agreement with the Snellen score. This study 
suggested a dissociation between the grating cut-off score and the 
Snellen acuity for patients with macular degeneration. The study 
concluded that contrast sensitivity measurements demonstrated 
central visual deficits not apparent with Snellen testing. 
Owsley et al.4 7 demonstrated that sensitivity for stationary 
gratings of low spatial frequency remained the same throughout 
adulthood in subjects with no retinal pathology. At higher spatial 
frequencies, sensitivity decreased with age beginning at age 40 to 50 
years. They also demonstrated that when a low spatial frequency 
was drifted, the motion enhancement was markedly diminished in 
adults over 60 years, implying an impairment of temporal processing 
in the elderly. These authors suggested that decreased retinal 
illuminance characteristic of the aged eye could account for a large 
part of older adults' deficit in spatial vision, but appeared to play a 
little role in their deficit in temporal vision. 
Loshin and White48 determined contrast sensitivity functions 
for a large group of patients with macular degeneration. They found 
a substantial loss of contrast sensitivity across all spatial frequencies, 
not just the high frequencies as indicated by Snellen visual acuity. 
In addition, they found that Snellen visual acuity measurements 
were somewhat variable and usually worse than would be predicted 
based on eccentricity alone. When compared with resolution acuity 
(calculated from the high-frequency cut-off of the CSF), the Snellen 
visual acuity of a patient with ARMD was considerably worse. From 
this data, the authors concluded that CSF is a useful tool in 
determining the visual characteristics of a patient with ARMD and 
that CSF information could be useful in predicting performance 
through an optical/low vision aid. 
Lennerstrand and Ahlstrom49 studied contrast sensitivity m 
patients with ARMD. The researchers compared the subjective visual 
impairment of discrimination/mobility with the amount of reduction 
of Snellen visual acuity and contrast sensitivity. Contrast sensitivity 
was tested using two methods. One was the conventional method of 
presenting gratings of sinusoidal luminance profile on a TV monitor. 
The other consisted of printed charts with optotypes at different 
contrast levels. The study found that contrast sensitivity 
measurements correlated better than Snellen values of visual acuity 
to the subjective assessment of visual impairment in patients with 
ARMD. Contrast sensitivity was determined to be fairly well suited 
to identify patients with difficulties in orientation by means of 
vision: e. g., the ability to move around in unfamiliar settings, 
recognize faces, and watch TV. Snellen visual acuity values were not 
helpful in prognosticating problems of visual orientation. On the 
other hand, contrast sensitivity was not correlated with the ability 
of visual discrimination: e. g., the ability to read printed text or 
subtitles on TV. In this respect, Snellen visual acuity measurements 
were found to be more useful. These data were later supported by 
Wilcox and Burdett50. 
Low contrast charts were used by Kleiner et ai.51 to investigate 
the possibility that patients with drusen have visual deficits not 
detected by Snellen charts. The drusen group read fewer letters 
than the control group on all the charts tested. the difference 
increased as the contrast decreased. The results showed a loss of 
contrast sensitivity with increasing drusen. Low contrast charts may 
be useful for measuring visual loss not detected by the standard 
Snellen charts. 
Richer29 presents contrast sensitivity evaluation as a part of a 
testing protocol for discerning subtle pathologic and functional 
changes in vision. Lu and Zhang52 reported that contrast sensitivity 
reduction at medium and high spatial frequencies of the fellow eyes 
in cases of unilateral ARMD suggested that CSF may be useful in the 
diagnosis of subclinical ARMD . 
In three studies, Mayer et aJ.53,54,55 suggested that flicker 
sensitivity can be used as a predictive test for exudative ARMD. the 
stimulus was a foveal, long-wavelength, low spatial frequency 2.8 
degree-circle in a equiluminant (photopic) surround. The authors 
speculated that sensitivity loss between 10 and 40Hz is a good 
predictor of which eyes will develop exudative ARMD . 
AMSLER GRID 
In 1953, Marc Amsler described the earliest symptoms of 
diseases of the maCL1laS 6. He reported that early functional 
symptoms of macular diseases consisted on the one hand of 
metamorphopsia and on the other hand of a relative scotoma. He 
designed the grid pattern that bears his name. The charts measure 
1 Ocm2 and are most commonly lined at 5mm intervals. When the 
chart is held at the recommended distance from the eye (28-30cm), 
each square subtends an angle of 1 degree. 
The Amsler grid is a suprathreshold target and thus may fail to 
detect a relative scotoma. \Vall and May5 7 reported that if the grid 
is viewed through 3 cross-polarizing filters creating low luminance 
conditions, the test is far more useful and provided a rapid and 
sensitive technique for the evaluation of the central 10 degrees of 
visual field in patients with maculopathies. This study supports an 
earlier study by Wall and Sadum5 8. 
ARMD could be considered a transition from normal retinal 
changes to pathological processes. In a pilot study by Cheng and 
Vingrys59, the visual functions of 11 pre-ARMD and 11 early ARMD 
subjects were studied. In addition to compromised visual acuity, 
losses in central visual field, color vision, and visual adaptation, a low 
contrast Amsler grid proved to be the most sensitive to central field 
defects and that the desaturated panel D-15 gave many false 
positives among normal elderly subjects. The results also indicated 
foveal sparing in early ARMD. 
PURPOSEOFTHESTUDY 
The mairi purpose of the present study is to develop a test or 
battery of tests that can be used by the clinical practitioner to 
identify at-risk patients for the development of ARMD. These tests 
concentrate in three areas: 
1. Functional visual tests 
2. Tests evaluating antioxidant protection including dietary 
intake and blood levels of antioxidants 
3. Routine blood chemistry tests 
A second purpose of this study is to provide normative data for 
a larger, nationwide study. The nationwide study is a multi-center, 
double-masked project on macular degeneration. 
It is beyond the scope of this study to analyze all the data 
provided to the larger, nationwide project. 
METHOD 
Two groups of subjects, those with age-related macular 
degeneration and those without the condition ("normals'), were 
selected from volunteers who responded to newspaper articles, TV 
reports, and direct solicitations at senior citizen centers. Subjects 
were required to be age 50 or older and to have good general health. 
In the normals group, all subjects were required to be male in order 
to gender-match the subjects participating in the multi-center 
project. All subjects participated in a detailed scree1iing interview. 
The interview was designed to exclude individuals who had systemic 
or ocular diseases with retinal manifestations, persons who had had 
cataract surgery within the last six months, individuals with 
glaucoma or lOPs . greater than 26mmHg, persons on medications that 
cause retinal side effects, or individuals who · were using a 
multivitamin/mineral supplement five or more times per week for 
two out of three years. 
contained in Figure 1. 
A copy of the exclusion interview form is 
All potential subjects were also given a dilated 
fundus examination to detect any other ocular conditions that might 
exclude them from the study. Those with severe and unstable 
cardiovascular disease, diabetes mellitus, chronic alcoholism/drug 
abuse, or those with previous laser photocoagulation for ARMD, 
advanced exudative ARMD, central serous retinopathy, optic atrophy, 
pathologic myopia, angoid streaks, macular hole, retinal vein 
occlusion, active uveitis, POHS, or other sight-threatening 
retinopathies, or other retinal degenerations were also excluded from 
the study. Following an explanation of the study, all subjects signed 
an informed consent form (See Appendix A). Each subject was paid 
ten dollars for each visit to the clinic to participate in the study. 
Twenty control subjects began the study; 18 completed. Three dry 
ARMD subjects began the study; two completed. 
EYE EXAMINATION 
All subjects participated 111 an eye examination every six 
months. The control subjects completed three eye examinations 111 
the course of one year. The ARMD group completed four 
FIGURE ·1 
EXCLUSION CHART 
PATIENT'S NAME DATE 
GENERAL EXCLUSION CRITERIA: COMMENTS/DATES 
Multivitamin and/or mineral use 
5 or more times per week 
for 2 out of 3 yeats. Identify 
all meds; vitamins, etc. curtently 
taking 
Diabetes Mellitus and/or 10 or 
more rnlcroaneurlsms/ 
retinal hemrnorhages In either eye 
Severe and unstable Cardiovascular 
disease or CHF 
Chronic alcoholism or drug abuse 
Personality Disorder or use of major 
tranquilizers 
OCULAR EXCLUSION CRITERIA: 
Previous laser photocoagulation for ARM 
Advaneed exudative ARM In either eye 
Central serous retinopathy 
Optic atrophy 
Surface wrinkling retinopathy severe 
enough to produce folding and/or 
lhcteased tortuosity of retinal vessels 
Pathologic myopia 
Angold streaks 
Macula hole 
Retinal vein occlusion, active uveitis, 
presumed ocular histoplasmosis syndrome, 
other sight-threatening retinopathies, or · 
other retinal degenerations 
Other ocular diseases, conditions, or 
previous retinal or ocular surgical 
procedures, the effects of which may 
now or In the future complicate assess-
ment of the progression of ARM or 
Cataract, I.e., ALT, RK, Trebeculectomy, 
cryo (except for a repair of a retinal hole), 
corneal transplant, radiation therapy, 
corneal or scleral laceration. 
Uncomplicated cataract surgery 6 or more 
months before Is acceptable •. 
Current or likely need for systemic or ocular 
medication that Is toxic to the lens, retina, 
or optic nerve, I.e., Plaqulnll, Chlorpromazine, 
Deferoxamlne, Tamoxlfen, Phenothlazlnes, 
ethambutol, or steroids, etc. 
Glaucoma or lOP > 26 mmHg 
Cataract surgery within 6 months 
Comments/Dates 
examinations 10 the course of eighteen months. The eye examination 
procedures for both groups were identical and included: best visual 
acuity through the patient's habitual lenses both at 6m and 40cm; 
pinhole if necessary to determine if reduced visual acuity was 
refractive in nature; slit lamp examination to evaluate the openness 
of the angle; intraocular pressure using Goldmann tonometry. 
AMSLER GRID 
Each patient's eyes were evaluated using an Amsler grid 
through threshold Stereo Optical's T.A.G. 100 polarized glasses worn 
over the habitual lenses. Room lights were standard 8-12 foot 
candles. The Amsler grid test was conducted monocularly. A 
drawing was made of any distortions or scotomas found and a 
numerical score was recorded to correspond to the coordinates of the 
boxes of the grid that were reported missing or distorted. When no 
distortions were found, the recording 0.0 was noted. 
CONTRAST SENSITIVITY 
Each subject was tested ustng the Vector Vision self-stick 
intermediate (6Hz) declining contrast test strip which was applied to 
the white, back side of the white on black Stereo Optical Amsler Grid 
test. The subject held the card 40cm from the eyes wearing the 
habitual lenses. The test was conducted monocularly. The subject 
identified the largest number test circle with vertical stripes that the 
subject could discriminate. Room illumination was standard room 
lighting. 
PUPIL D ILA TI 0 N 
Following the above tests, the subject's eyes were dilated usmg 
one drop of Paremyd solution ou . The expected risks and effects of 
dilation were discussed with each subject prior to instillation of the 
drops. 
HEIGHT, WEIGHT, FRAME SIZE, IRIS COLOR 
Following instillation of the dilation drops, each subject was 
weighed in kilograms on a standard sliding weight scale. Height was 
obtained by extending a rod from the scale to the top of the subject's 
head. Height was recorded in centimeters. From the subject's height, 
ideal body weight was calculated. Frame size was obtained visually 
and by asking the subject to compare his/her frame size against 
others of similar height and gender. Iris color was determined by 
observation and by asking the subject to identify his/her eye color. 
This data was not used in the present study, but was supplied to the 
Veterans Affairs Medical Center in North Chicago for inclusion in the 
multi-center study. 
DARK ADAPTATION 
Following the instillation of the dilation drops, each subject was 
seated in a dark room and a blindfold placed over both eyes for a 
period of 35 minutes. The researcher was present in the dark room 
with the subject to insure compliance. 
NUTRITION QUESTIONNAIRE 
During dark adaptation, the researcher used a standardized 
Veterans Administration nutrition questionnaire, Figure 2, to 
interview each subject. Information on occupation, date of birth, 
recreation/physical activity, allergies, medical diagnosis, current 
medications/multivitamin/mineral supplementation, smoking, 
alcohol consumption, phosphate beverage consumption, diet 
restrictions/status, and questions concerning digestion problems 
were obtained. The questionnaire was completed each six month 
visit. The data were not used in the present study, but were 
submitted for inclusion in the multi-center project. 
FOVEAL RED THRESHOLD AUTOMATED PERIMETRY 
Following 35 minutes of dark adaptation and with dilated 
pupils, each subject participated in a dark-adapted foveal red 
threshold test on the Humphrey Field Analyzer. The Humphrey Field 
Analyzer was modified to simulate a Tubinger perimeter. To set up 
the equipment for testing, the back and front of the instrument were 
removed to expose the internal bowl. Black cloth and tape were used 
FIGURE 2 l'oRM • Dun 1 
Patient Code 
...____ 
VA MULTICENTER 0YfOMETRY/DtETETIC ARM STUDY 
ADMISSION/NUTRITION QUESTIONNAIRE 
Sex lit (in) Wt (Lbs) Bodv Frame Size 
(M) (F) (S) (M) (L) 
IBW (Lbs) 
Admission Date: _____________ Usual Wt (Lbs): -------------
Recent Wt Change? gain loss Lbs 
----
Name: SSN: 
----------------------- -------Lust M First 
Date Of Birth:----- ----- ----- Occupation: --------------
Month Day Year 
Recreatio.n, Physical Activity: 
------------~-----------------------
List Allergies: Describe Symptoms Briefly: 
Food Medlca~ti~o-n _______________________ r----------------------
Others ------------------------------~----------------
Medical Diagnosis: Primary 
------------------------------------
..... 
Secondary Diagnosis: 
Dosage/ Prescribed: 
edications: 
cs 
Current M 
Diur-eti 
Laxativ 
Vitamin 
Antlcoa 
Others 
es 
s•• 
guJants 
Smoking: yes ____ no __ _ 
AJcohol intake: yes ao 
---Phosphate Beverages: yes no ___ _ 
Frequency 
packs per day ___ _ 
ounces per day ___ _ 
ounces per day ___ _ 
Dietary Restriction (Enter No. Applkable): _____ _ 
yes 
1 - Reg 3 - Low NA S - Diabetic 7 • High Fiber 9 - Low Residue 
2- Mech 4- Low Fat/Chol 6- Wt Red 8 - Low Pro 10- Vegetarian 
Nutritional Status (Enter One No.): 
1- Normal 
2 - Mildly Compromised 
3 - Moderately Compromised 
4 • Severely Compromised 
no 
•• Per review with attending physician, patient can discontinue current vitamin supplement and begin 
OcuGuardR, RD will alert ODor Gastroenterologist to the presence of side effects and monitor compli-
ance during the first three months. 
Completed By:-----------------
R.D. Investigator 
Date: 
------------------
I 
·'-" 
VA MuLTICENTEn OJ•ToMETRV/DIETETIC ARM STUDY 
REPORT OF CHANGES AND PRoBLEMS 
'atient Code 
nnseline 6 Month 12 Month 
Date: Mo/Day /Year 
Weight (lbs) 
%1UW 
Digestion and Absorption 
(Enter No. Applicable) -
Nausea: 0 None, 1 Mild, 2 Se\ere 
Diarrhea: 0 None, 1 Mild, 
2 Se\·ere 
Constipation: 0 None, 1 Mild, 
2 Severe 
Vomiting: 0 None, 1 Mild, 2 Se\'~re 
Distention and/or Bloating: 
0 None, 1 Mild, 2 Severe 
Excessive Gas: 0 None, 1 Mild, 
2 Se\·ere 
Malabsorption: 0 None, J Mild, 
2 Senre 
Comments: (May include problems wHit the Food Intake Record) 
Baseline: 12 Month: 
6 Month: 18 Month: 
Date: 
FoRM • Dn!"r 2 
18 Month 
:ompleted By: -------- -----------
R.IJ. lmestigator ------------------
to remove all light leaks from entering the bowl. The small diamond 
fixation LED target was used and was neutralized using a neutral 
density filter. A 660nm filter was placed over the projection unit. A 
custom Goldman V target (1.72) 1 pt. was used. The internal light of 
the perimetry bowl was disconnected. The foveal threshold selection 
from the main menu was turned on. Calculated trial lenses, based on 
a target distance of 33cm, were put in place during the test. The test 
was performed monoculary and the patient's eye not being tested 
was patched. The foveal red threshold for each eye was measured 
using the ascending staircase method with a 200msec stimulus 
presentation. This method is the same as that established and used 
by Sunness3 8. The results for each eye were recorded in decibels. 
Dll_.ATED FUNDUS EXAMINATION 
Following completion of the foveal red threshold test, each 
subject was sufficiently dilated to complete a dilated fundus 
examination, using direct ophthalmoscopy, 90D slit lamp examination 
of the posterior pole, and indirect ophthalmoscopy if necessary. Each 
subject's crystalline lenses wei·e evaluated for cataract formation. 
Grades NO through N4 were used to rate nuclear sclerosis and Grades 
CO through C4 were used to designate the level of cortical spoking. 
Posterior subcapsular cataracts were noted, but not graded. The 
retina of each eye was evaluated for macular and disk abnormalities; 
findings were noted in the subject's chart. 
FUNDUS PHOTOGRAPHY 
Following the dilated fundus examination, 35mm slides were 
taken of each subject's retinae. Professional Kodak daylight 64ASA 
slide film was used. The fundus camera was set at 35 degrees angle 
of coverage and the flash setting was at 50. Three or more slides 
were taken of each eye. The film was processed by Kodak in Palo 
Alto or San Francisco. The slides were submitted to an independent 
professional optometric slide reader associated with the multi-center 
project. The slide interpreter had no knowledge of the subjects. 
FOOD INTAKE DIARY AND CONSULTATION 
Following the photography, subjects were seated in a 
consultation room. At that time, any findings of the examination 
were disclosed to the subject. A standardized Veterans 
Administration food intake diary, Figure 3, was presented to the 
subject with an explanation of how to complete the form and to 
return it to the researcher in the self-addressed envelope provided. 
The subjects were instructed to identify on the food intake diary all 
substances eaten or drunk. The diary was to be completed for three 
continuous three-day period to include a Friday, Saturday, and a 
Sunday within the next two weeks following that clinic visit. If the 
food intake diary was not returned, the researcher contacted the 
subject by telephone to request completion. 
SUPPLEMENTATION TRIALS 
The control group did not participate 111 this aspect of the 
study. The ARMD group of subjects were randomly selected to 
receive one of two unidentified capsule supplements. One capsule 
was a starch placebo; the other was an antioxidant vitamin/mineral 
nutrient supplement available without a prescription and 
manufactured by OcuguardR. the capsules were identical in 
packaging, taste, color, and smell. Which capsule was the placebo 
and which capsule was the active vitamin/mineral supplement was 
unknown to the researcher and to the subjects (double masked). The 
capsules were provided by an independent source not connected to 
the study. Each ARMD subject was instructed orally and in writing, 
Figure 4, how to use the capsules properly. The subjects were 
instructed to take one capsule in the morning with breakfast and one 
capsule in the evening with dinner. Two week following the ARMD 
subject's first visit to the clinic, the researcher telephoned the subject 
to check on compliance with the study requirements and to answer 
any questions. Refills of the supplement were available to the ARMD 
subjects at all times. If the ARMD subject experienced any adverse 
reactions to the supplements at any time, the subject was instructed 
to discontinue use and call the researcher immediately. None of the 
subjects experienced any adverse reactions to the supplements. 
FIGURE 3 
VA MULTICENTER 0PTOMETRY/DIETETI~ ARM STUDY 
FooD INTAKE REcoRD 
PA1ll!Nl' FORM 
6Mo. 
'atient Code 
------)ate 
----------------
Record intake for three days. 
Include a weekend and a weekday. 
MEALS SPECIFY KIND 
Breakfast: 
Toast 
Bevera2e 
Milk 
Cereal 
El!l! 
Bacon, Sausae:e 
Fruit Juice 
Butter 
Sue:ar- Jelly 
Other 
A.M. Snack 
Lunch: 
Bread 
Bevera2e 
Milk 
Meat Grouo 
Potato 
Vee:etable 
Salad Dressin2 
Dessert 
Butter 
Su2ar 
Other 
P.M. Snack 
Dinner: 
Bread 
Bevera2e 
Milk 
Meat Groun 
Potato 
Vee:etable 
Salad Dressinl! 
Dessert 
Butter 
Su2ar 
Other 
Evening Snack 
~eview Completed By:------------------
R.D. Investigator 
SERVING PoRTioN 
--'-
FIGURE 4 
DIETARY SUPPLEMENT STUDY 
PATIENT INSTRUCTION SHEET 
THANK YOU FOR AGREEING . TO PARTICIPATE IN THIS STUDY. 
WITH YOUR HELP . WE WILL GAIN IMPORTANT 
INFORMATION THAT MAY HELP MANY PEOPLE IMPROVE 
THEIR SIGHT. 
WE ASK THAT YOU FOLLOW THESE SIMPLE INSTRUCTIONS 
AT HOME DURING THE PROGRESSION OF THE STUDY: 
1. TAKE YOUR ASSIGNED DIETARY SUPPLEMENTS 
TWICE PER DAY, ONE CAPSULE \VITH BREAKFAST 
AND ONE CAPSULE \VITH DINNER. 
2. PERFORM THE AIVISLER GRID AT HOME AS 
INSTRUCTED DURING YOUR FIHST VISIT TO 
PACIFIC UNIVERSITY. 
3. WE WILL CHECK IN WITH YOU AFTER TWO WEEKS 
AND MONTHLY BY TELEPHONE TO SEE HOW YOU 
ARE DOING AND TO ANSWER ANY QUESTIONS. 
IF, AT ANY TIME, YOU EXPERIENCE ANY ADVERSE 
REACTIONS . TO THE DIETARY SUPPLEMENTS, DISCONTINUE 
USE AND CALL ONE OF THE RESEARCHERS AS SOON AS 
POSSIBLE: 
DR. DIANE YOLTON: WORK: 357-6151, EXT. 2282 
DR. SALISA WILLIAMS: WORK: 357-6151, EXT. 2530 
FRAN TABOR, INTERN: HOME: 359-0742 
BLOOD CHEMISTRY ANALYSIS 
The subjects in the control group had their blood drawn once at 
the conclusion of the study. Blood samples were drawn from the 
ARMD subjects by a certified plebotomist at the beginning of the 
study and at the conclusion of the study. Standard CBC/differential, 
SMA6 and 12 serological tests were performed by a commercial 
medical laboratory/hospital laboratory. The results of the test were 
sent to the researcher by the laboratory. 
AMSLER GRID 
The ARMD subjects were gtven an identical Stereo Optical 
Amsler Grid T.A.G. with polarized glasses as the one used in the 
clinical visit. The polarized lenses were turned so that the minimal 
amount of light entered the eye. The pins that rotated the polarizers 
were removed by the researcher so the the polarizing angles could 
not be changes by the subject. The ARMD subjects were given oral 
and written instructions, Figure 4, on the proper use of the horne 
Amsler grid. ARMD subjects were instructed to call the researcher if 
there were any changes in the appearance of the grid during the 
course of the study. 
RESULTS 
Eighteen of the twenty control subjects and two of the three 
ARMD subjects completed the study . The control ("normals") subjects 
were followed for one year and the ARMD subjects were followed for 
eighteen months . 
The foveal red threshold automated perimetry test, nutritional 
data from the food intake diaries, contrast sensitivity test, 
Amsler grid test and blood chemistry tests were analyzed for 
purposes of this study . . 
It should be noted that, because the ARMD group contained 
only three participants, statistics comparing differences between the 
control group and the ARMD group could not be conducted . A 
minimum of seven subjects 111 each group are necessary to conduct a 
statistical analysis. 
FOVEAL RED THRESHOLD AUTOMATED PERIMETRY 
A comparison of the mean foveal red thresholds of 17 normals 
and weighted average of three ARMD patients over all trials is 
summarized in Table 1. One normal subject's data was dropped due 
to red/green color anomaly. 
Table 1. Mean Foveal Red Thresholds 111 Decibels of the 
Normals and the ARMDs 
MEAN FOVEAL RED THRESHOLDS IN DECIBELS 
m OS 
NORMALS 25.3 25.4 
ARMD 15.2 15.9 
The results indicate that the foveal red thresholds of the normals 
were notably higher than those of the ARMD group. 
CONTRAST SENSITIVITY 
A comparison of the mean contrast sensitivity of 18 normals 
and the weighted average of three ARMD patients over all trials is 
shown in Table 2. 
Table 2. Mean Contrast Sensitivity @ 6cc/degree of the 
Normals and ARMDs 
MEAN CONTRAST SENSITIVITY @ 6cc/Degree 
NORMALS 8.0 
ARMD 4.4 
The results indicate that the normals are able to detect notably lower 
contrast targets than are the ARMDs. 
AMSLER GRID 
A comparison of metamorphopsia of the normals and the 
ARMDs is indicated in Table 3. 
Table 3. Amsler Grid Metamorphopsia Ill the Normals and 
ARMDs 
AMSLER GRID METAMORPHOPSIA 
HORIZOl\TT AL VERTICAL SCOTOMA 
NORMALS 0.0 0.0 0.0 
ARMD 2.47 2.78 34.9 
The results indicate that the normals did not experience any 
metamorphopsia, while the ARMD subjects showed horizontal and 
vertical distortion as well as scotomas. 
NUTRITIONAL DATA ANALYSIS 
In order to age-match the normal subjects of this study with 
the subjects in the larger multi-center project , the nutritional data of 
the five youngest control group members were dropped. The 
nutritional intake data were analyzed for the 13 remaining normals. 
The nutritional analysis was conducted by the Veterans Affairs 
Medical Center. The results are shown in Table 4. 
Table 4. Nutritional Analysis of the "Normals" (Control) Group 
RDA MEAN %RDA +1-% 
Energy (Kcal) 2250 
Protein g 63 102 162% +62% 
Carbo g 258 
Fat g 86.0 
Crude Fiber g 5.12 
Diet Fiber g 8.23 
Iron mg 10 20.2 202% +102% 
Selenium ug 70 132 189% +89% 
Zinc mg 1 5 8.83 59% -41% 
Magnesium mg 350 206 59% -41% 
Copper mg 0.9 
Vitamin A RE 1000 1429 143% +43% 
Vitamin C mg 60 89 148% +48% 
Vitamin E mg 10 2.01 20% -80% 
Riboflavin mg 1.4 6.51 465% +365% 
Manganese mg 2.00 
Potassium mg 2947 
Sodium mg 3461 
Calcium mg 800 719 90% -10% 
Phosphorous 800 1389 174% +74% 
mg 
H20 ml 1 5 1 6 
Thiamin mg 1.2 4.56 380% +280% 
Niacin mg 1 5 29.4 196% +96% 
Vitamin B6 mg 2.0 1. 73 87% -13% 
Vitamin B12 2.0 4.1 7 209% +109% 
meg 
Folic Acid meg 200 205 103% +3% 
Pant mg 3.63 
Chol mg 418 
182C2 g 12.5 
18C3 g 0.91 
Mono g 16.6 
PuPA g 11.7 
SaFA g 28.3 
The results indicate that the diets of the control subjects are deficient 
in zinc, magnesium, vitamin E, calcium. and vitamin B6. However, 
their diets appear to be rich in iron, riboflavin, phosphorous, thiamin, 
niacin, and vitamin B 12. 
No nutritional analysis data of the ARMD subjects was available. 
BLOOD CHEMISTRY ANALYSIS 
Blood chemistry values of the normals and the ARMDs were 
analyzed by the Veterans Affairs Medical Center. The results are 
shown in Table 5 (Normals) and Table 6 (ARMDs). Again, in order to 
age-match to the larger multi-center project, the blood chemistry 
values of the five youngest members of the control group were 
dropped from the analysis. The data of the 13 remaining normals for 
one blood test at the conclusion of the study was analyzed. A 
weighted average of the three ARMD patients for two blood 
chemistry tests, one at the beginning of the study and one at the 
conclusion of the study, was analyzed . 
Table 5. Blood Chemistry Values of the Normals 
Range of Values Mean +1-% 
Glucose (mg/dl) 60-110 103 
BUN (mg/dl) 8-25 15.0 
Creatinine (mg/dl) 0.5-1.5 1.00 
Sodium (mEq/L) 134-146 143 
Potassium (mEq/L) 3.5-5.1 4.43 
Chloride (mEq/L) 92-109 104 
C02 (mEq/L) 31.5 
Phosphate (mg/dl) 2.6-4.6 
Calcium (mg/dl) 8.0-10.4 9.46 
Total Protein (g/dl) 5.6-8.4 6.87 
Albumin (g/dl) 3 .4-5 .4 3.99 
Alk. Phosph. (U/L) 25-115 122 +6% 
SGOT (U/L) 0-40 25.6 
LDH (U/L) 50-240 159 
SGPT (U/L) 0-40 
Tot. Bilirubin 0.2-1.5 0. 70 
(mg/dl) 
Cholesterol (mg/dl) <200 210 +5% 
Triglyceride 30-135 197 +46% 
(mg/dl) 
Uric Acid (mg/dl) 2.4-7.5 5.9 
Tot Lymph Count 630-3170 
WBC (cells/mm3) 6.87 
RBC (106/ul) 4.8-6.0 4.68 -3% 
Hemoglobin (g/dl) 14-18 m 14.9 
Hematocrit (%) 40-52 m 44.0 
MCV 80-95 m 94.0 
MCH (pg) 2 7-32 31.9 
MCHC (g/dl) 32-36 33.9 
Neutrophils (%) 40-60 66 . 1 +10% 
Lymphocytes (%) 20-40 22.9 
Monocytes (%) 4-8 7.27 
Eosinophils (%) 1-3 2.66 
Basophils (%) 0-1 0.86 
Table 6. Blood Chemistry Values of the ARMDs 
Range of Values Mean +1-% 
Glucose (mg/dl) 60-110 97.6 
BUN (mg/dl) 8-25 14.4 
Creatinine (mg/dl) 0 .5-1.5 1.12 
Sodium (mEq/L) 134-146 140.8 
Potassium (mEq/L) 3.5-5.1 4.48 
Chloride (mEq/L) 92-109 102 
C02 (mEq/L) 26 
Phosphate (mg/dl) 2.6-4.6 3.43 
Calcium (mg/dl) 8.0-10 .4 9.82 
Tot. Protein (g/dl) 5.6-8.4 6.88 
Albumin (g/dl) 3.4-5.4 4.04 
Alk. Phosph. (U/L) 25-115 84 
SGOT (U/L) 0-40 1 5 
LDH (U/L) 50-240 177.2 
SGPT (U/L) 0-40 14 
Tot. Bilirubin 0.2-1.5 0 .50 
(mg/dl) 
Cholesterol (mg/dl) <200 217.60 +8.8% 
Triglyceride 30-135 254.8 +88.7% 
(mg/dl) 
Uric Acid (mg/dl) 2.4-7.5 4 .65 
Total Lymph Count 630-3170 
WBC (cells/mm3) 7.62 
RBC (106/ul) 4.8-6.0 4.40 -3.6% 
Hemoglobin (g/dl ) 14-18 m 13.54 
Hematocrit (%) 40-52 m 40.90 
MCV 80-95 m 93.16 
MCH (pg) 2 7-3 2 30.84 
MCHC (g/dl) 3 2-3 6 33 . 14 
Neutrophils (%) 40-60 58.64 
Lymphocytes (%) 20-40 31.28 
Monocytes (%) 4-8 6.46 
Eosinophils (%) 1-3 2.60 
Basophils (%) 0- 1 1.03 
A companson of the blood chemistry values of the normals (Table 5) 
and the ARMDs (Table 6) indicates that, although both groups show 
high levels of triclycerides, the ARMD group shows a level almost 
double that of the controls. Although the normals show higher than 
usual levels of alkaline phosphatase and neutrophils, they also show 
higher than usual levels of these blood components than the ARMD 
group. 
DISCUSSION 
The present study represents an effort to develop a protocol 
testing method of identifying individuals who are likely candidates 
to develop age-related macular degeneration (ARMD). The subjects 
who participated in this study were part of a larger, nationwide, 
multi-center, double-masked study conducted by the Veterans 
Affairs Medical Center in North Chicago, Illinois. In that study, most 
participants were male and the average age was mid-seventies. 
The "normals" control group in the present study consisted of 
18 male subjects over the age of 50. In order to gender and age 
match the subjects in the larger study, the data of the five youngest 
members of the control group were not analyzed in the nutritional 
intake and blood chemistry analyses. However, in the analyses of 
contrast sensitivity, Amsler grid, and red foveal threshold automated 
perimetry, the data of all 18 normals is included. 
Because of the small number of subjects in the ARMD group, 
statistical analyses could not be performed. This study analyzed the 
weighted averages of the three ARMD patients over all trials for the 
contrast sensitivity, Amsler grid, red foveal red threshold automated 
perimetry, and the blood chemistry analyses. 
The foveal red threshold automated perimetry test appears to 
be an excellent tool for identifying who are likely individuals to 
develop ARMD in the future. Even without the benefit of statistical 
analysis, it is clearly evident that there is a significant drop in foveal 
sensitivity as ARMD develops. This finding supports those of earlier 
researchers, such as Sunness39. 
The results of the contrast sensitivity test also revealed a 
notable difference between the normals and the ARMDs. The ARMD 
subjects showed a reduced ability to distinguish targets of low 
contrast. Since the average age in the present study of the normals 
group was 68.1 years and that of the ARMD subjects was 75.6 years, 
the differences appear to be the result of ARMD rather than age . 
These data support the findings of Loshin and White4 8 and others 
who indicate a substantial loss of contrast sensitivity across all 
spatial frequencies with the development of ARMD. 
The nutritional analysis was not completed for the ARMD 
subjects, so comparisons between the ARMD group and the "normals' 
control group could not be made. It is extremely interesting to note, 
however, that the normal group showed deficiencies in zinc, 
magnesium, vitamin E, calcium, and vitamin B6. Zinc and vitamin E 
are antioxidant vitamins/minerals that are known to be required to 
quench the free-radicals that may be responsible for the 
development of ARMD. It will be very interesting to learn whether 
any of the normals develop ARMD in the future. 
The blood chemistry analysis showed that the triglyceride level 
of the ARMD subjects was almost double that of the control group, 
although both groups had about the same higher than usual 
cholesterol levels. 
levels to ARMD. 
There are no studies linking high · triglyceride 
However, the Eye Disease Case Control Study30, 
discussed above, does suggest that high serum cholesterol levels are 
indirectly linked with cardiovascular disease and ARMD. 
In summary, this study should be regarded as a preliminary 
pilot study. The numbers of subjects in the ARMD group was too 
small for statistical analyses to be performed . In spite of this 
difficulty, however, notable differences between the "normals" 
control group and the ARMD group were observed. These data 
suggest that further research is necessary. Perhaps if the ARMD 
group had been larger, the differences between the two groups 
would have withstood statistical scrutiny. 
Based on the observations of this study, there appears to be a 
viable protocol for use by optometrists and ophthalmologists to 
determine who are likely individuals to develop ARMD in the future. 
The testing protocol recommended should include: 
1. Foveal Red Threshold Automated Perimetry. The use of a 
660nm filter over the projection unit; Goldman V target; 
neutral density filter over the small diamond; and 
removal of all light leaks should be employed. The 
patient should be dark-adapted and pupils dilated. 
This method was developed by Sunness41 in 1989 and 
appears to be an excellent predictor of future ARMD. 
The present study suggests that if the results of the 
foveal red threshold test start to drop below 20db, 
there is a likelihood that the patient may be develop-
ing ARMD. 
2 . Contrast Sensitivity. This test should employ the Vector 
Vision intermediate (6Hz) declining contrast test strip. 
The subject should be tested ar 40cm from the eyes 
wearing habitual lenses. Contrast levels under 5.0 may 
suggest ARMD or other ocular disease. 
3. Amsler Grid. This test should be performed usmg the 
Stereo Optical T.A.G. 100 polarized glasses worn over the 
habitual lenses. The test should be performed 
monocularly under minimal luminance conditions. 
Horizontal or vertical distortions or scotomas could be 
indicative of ARMD. 
4. Nutritional Data. Analysis of food nutrients m the diet 
via food diaries analyzed over a period of time may 
suggest risk factors associated with the development of 
ARMD. 
Since nutritional data of the normals could not be compared 
with the ARMDs, guidelines in this area will have to wait 
for the results of the multi-center study. 
5. Blood Chemistry Analysis. Analysis of blood chemistry vta 
the CBC and SMAC may suggest some risk factors for 
developing ARMD. Although the data of this study suggested 
that a high triglyceride level could be a risk factor, the number 
of subjects in the ARMD group is too small to draw any 
valid conclusion. The guidelines here will have to wait for 
the results of the multi-center study. 
This study did establish that there is a strong suggestion that a 
testing protocol for identifying which patients are at risk for 
developing ARMD in the future can and should be developed . The 
predictability of these tests will likely be refined as part of the 
larger, nationwide, multi-center project of the Veterans Affairs 
Medical Center concludes. However, research in the area of ARMD 
needs to continue. As the population ages, more cases of ARMD are 
likely to occur. It is a challenge to researchers to find the causes, 
develop appropriate and cost-effective testing protocols, and the 
treatments necessary to bring the elusive eye disease under control. 
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APPENDIX A 
INFORMED CONSENT FORM 
Pacific University College of Optometry 
A. Title of Project: 
B. Principal Investigators 
c. Location 
D. Dates of Study 
The Visual Function and Dietary Intake 
of Males of Age 50 or Older 
Fran L. Tabor, Intern 
359-0742 
and 
Dr. Diane P. Yolton, OD, PhD 
357-6151, ext. 2282 
Pacific University Family Vision 
Clinic 
Forest Grove, Or 97116 
1993-1994 
Description of Study 
The purpose of this study is to evaluate the dietary intake 
and specific visual .functions of males 50 years of age and older 
who have healthy eyes and good general health. This study 
is part of a larger research project to determine whether an 
over-the-counter (OTC) multi-vitamin/mineral supplement 
taken twice daily can slow the progression of age related 
macular degeneration. The overall project includes other 
subjects from around the USA. 
If selected for participation in this study, you will coniplete a 
food intake diary for three days (one weekday and one 
weekend) once at the beginning of the one-year research time 
period and once at the end of the study. You will visit the 
Family Vision Clinic at Pacific University three times: this visit, 
at six months and at one year from the start of the research 
time period. During each visit, your eyes will be evaluated for 
any changes that might have occurred during the last six-
months. During your visit, your eyes will be dilated and you 
will be dark-adapted for 40 minutes. Following dark 
adaptation, your eyes will be evaluated using a field analyzer 
test and a constrast sensitivity test, two standard tests which 
are administered during a routine vision exam. You will be 
informed if unusual conditions are detected. 
Description of Benefits 
You will be paid $10 for your participation in this study (a total 
of $30 for 3 visits). You will be paid in for form of cash or a 
check at the time of each visit. 
If you have elected to participate in this study, you will have 
the advantage of close monitoring or your visual system at six-
month intervals at no cost to you. However, this monitoring is 
not a complete eye exam. It is a screening test to determine 
whether your vision remains normal. 
Description of Risks 
During each visit to the clinic, your eyes will be dilated. The 
drops used to dilate your pupils for the exam may cause 
temporary blurring and/or light sensitivity for 2-4 hours 
after optometric procedures. Slight risks of allergic 
reactions to the medications used and a very slight risk of 
causing elevated pressure in the eye exist. You will be 
screened for susceptibility to these conditions prior to dilation. 
In addition, you will be warned not to drive or operate 
dangerous machinery while your eyes are dilated. Sunglasses 
will be provided to you to reduce possible sensitivity to light. 
Confidentiality 
Records of this project will be maintained in a confidential 
manner and no name-identifiable information will be released. 
Compensation and Medical Care 
If you are injured or become ill during this experiment, it is 
possible that you will not receive compensation or medical care 
from Pacific University, the researchers, or any organization 
associated with this study. All responsible care will be used 
during this study to prevent any injuries. 
Offer to Answer Any Inquiries 
The researchers are happy to answer any questions that you 
may have at any time during the course of the study. Please 
feel free to call Fran Tabor at 359-0742. If you are not 
satisfied with the answers you receive, you may call Dr. 
James Peterson at 357-0442. 
During your participation in the project, you ·are not a Pacific 
University clinic patient or client for the purposes of the 
research. All questions should be referred directly to the 
researchers who will be solely responsible for any inquiries. 
As mentioned above, you will not be receiving complete 
eye, vision, or health care as a result of participation in this 
project. Therefore, you will need to maintain your regular 
program of eye, vision, and health care. 
Freedom to Withdraw 
You are free to withdraw your consent and to discontinue your 
participation in this study at any time without prejudice to you. 
I have read and understand the above. 
Printed Name --------------------------------------------
Signed Date ·-----------
Address Phone 
City -------------- State/Zip _______ _ 
Name and telephone number of a person who will know that you are 
are at Pacific University. 
Name Phone --------------
